Literature DB >> 10391859

Development of an antigen spot test for detection of coronavirus in bovine fecal samples.

F Gaber1, S Kapil.   

Abstract

We have developed a rapid and sensitive microimmunodot blot assay, the antigen spot test (AST), for the detection of bovine coronavirus (BCV) antigen from neonatal calf fecal samples. The AST procedure can be completed in 3.5 h, whereas the previously reported immunodot blot assays require 10 to 12 h. Ninety-six samples can be tested per membrane, and 10 membranes (960 samples) may be processed by a single technologist in 1 working day. The effects of detergents, oxidizing chemicals, chaotropic agents, and enzyme substrates in improving the sensitivity and signal-to-noise ratio of the AST were studied. Finally, the sensitivity and specificity of AST for the detection of BCV antigen were compared to those of a sandwich enzyme-linked immunosorbant assay (ELISA) and a hemagglutination assay (HA). Of 347 field samples tested by all three methods, 94.2% were positive by AST, 91.4% were positive by ELISA, and 86.7% were positive by HA. The sensitivity of the AST was determined to be 100% compared to the results of the ELISA reference method. The specificity of the AST was 67%, which reflects a lower limit of detection of 10(4) viral particles per ml in a 10% fecal suspension.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10391859      PMCID: PMC95724          DOI: 10.1128/CDLI.6.4.542-544.1999

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  22 in total

1.  Production, characterization, and uses of monoclonal antibodies against recombinant nucleoprotein of elk coronavirus.

Authors:  G C Daginakatte; C Chard-Bergstrom; G A Andrews; S Kapil
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

2.  Winter dysentery in adult dairy cattle: detection of coronavirus in the faeces.

Authors:  L J Saif; D R Redman; K V Brock; E M Kohler; R A Heckert
Journal:  Vet Rec       Date:  1988-09-10       Impact factor: 2.695

3.  Neonatal calf diarrhea: purification and electron microscopy of a coronavirus-like agent.

Authors:  E L Stair; M B Rhodes; R G White; C A Mebus
Journal:  Am J Vet Res       Date:  1972-06       Impact factor: 1.156

4.  Monoclonal antibody capture enzyme-linked immunosorbent assay for detection of bovine enteric coronavirus.

Authors:  C F Crouch; T J Raybould; S D Acres
Journal:  J Clin Microbiol       Date:  1984-03       Impact factor: 5.948

5.  Coronaviral enteritis of young calves: virologic and pathologic findings in naturally occurring infections.

Authors:  T J Langpap; M E Bergeland; D E Reed
Journal:  Am J Vet Res       Date:  1979-10       Impact factor: 1.156

6.  Experimentally induced coronavirus infections in calves: viral replication in the respiratory and intestinal tracts.

Authors:  L J Saif; D R Redman; P D Moorhead; K W Theil
Journal:  Am J Vet Res       Date:  1986-07       Impact factor: 1.156

7.  Coronavirus infection of the bovine respiratory tract.

Authors:  M S McNulty; D G Bryson; G M Allan; E F Logan
Journal:  Vet Microbiol       Date:  1984-09       Impact factor: 3.293

8.  The antigen spot test (AST): a highly sensitive assay for the detection of antibodies.

Authors:  P Herbrink; F J Van Bussel; S O Warnaar
Journal:  J Immunol Methods       Date:  1982       Impact factor: 2.303

9.  Development of protein A-gold immunoelectron microscopy for detection of bovine coronavirus in calves: comparison with ELISA and direct immunofluorescence of nasal epithelial cells.

Authors:  R A Heckert; L J Saif; G W Myers
Journal:  Vet Microbiol       Date:  1989-03       Impact factor: 3.293

10.  Studies on the relationship between coronaviruses from the intestinal and respiratory tracts of calves.

Authors:  D J Reynolds; T G Debney; G A Hall; L H Thomas; K R Parsons
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

View more
  1 in total

Review 1.  The next-generation coronavirus diagnostic techniques with particular emphasis on the SARS-CoV-2.

Authors:  Maged G Hemida
Journal:  J Med Virol       Date:  2021-03-26       Impact factor: 2.327

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.